Investor directory

Arranta Bio

Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
http://arrantabio.com
https://crunchbase.com/organization/arranta-bio
https://facebook.com/arrantabio
https://linkedin.com/company/arranta-bio
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=642212371

Iain Baird

Founder

1 past transactions

Captozyme

Acquisition in 2019
Biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch Nephure in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their bodies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.